| Modulation of tryptophan catabolism by regulatory T cells F Fallarino, U Grohmann, KW Hwang, C Orabona, C Vacca, R Bianchi, ... Nature immunology 4 (12), 1206-1212, 2003 | 1806 | 2003 |
| CTLA-4–Ig regulates tryptophan catabolism in vivo U Grohmann, C Orabona, F Fallarino, C Vacca, F Calcinaro, A Falorni, ... Nature immunology 3 (11), 1097-1101, 2002 | 1502 | 2002 |
| The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells F Fallarino, U Grohmann, S You, BC McGrath, DR Cavener, C Vacca, ... The Journal of Immunology 176 (11), 6752-6761, 2006 | 1270 | 2006 |
| T cell apoptosis by tryptophan catabolism F Fallarino, U Grohmann, C Vacca, R Bianchi, C Orabona, A Spreca, ... Cell Death & Differentiation 9 (10), 1069-1077, 2002 | 1166 | 2002 |
| Indoleamine 2, 3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells MT Pallotta, C Orabona, C Volpi, C Vacca, ML Belladonna, R Bianchi, ... Nature immunology 12 (9), 870-878, 2011 | 714 | 2011 |
| Aryl hydrocarbon receptor control of a disease tolerance defence pathway A Bessede, M Gargaro, MT Pallotta, D Matino, G Servillo, C Brunacci, ... Nature 511 (7508), 184-190, 2014 | 654 | 2014 |
| CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 C Orabona, U Grohmann, ML Belladonna, F Fallarino, C Vacca, R Bianchi, ... Nature immunology 5 (11), 1134-1142, 2004 | 384 | 2004 |
| Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy U Grohmann, C Volpi, F Fallarino, S Bozza, R Bianchi, C Vacca, ... Nature medicine 13 (5), 579-586, 2007 | 376 | 2007 |
| IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells ML Belladonna, JC Renauld, R Bianchi, C Vacca, F Fallarino, C Orabona, ... The Journal of Immunology 168 (11), 5448-5454, 2002 | 358 | 2002 |
| IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production U Grohmann, ML Belladonna, R Bianchi, C Orabona, E Ayroldi, ... Immunity 9 (3), 315-323, 1998 | 354 | 1998 |
| Functional expression of indoleamine 2, 3-dioxygenase by murine CD8α+ dendritic cells F Fallarino, C Vacca, C Orabona, ML Belladonna, R Bianchi, B Marshall, ... International Immunology 14 (1), 65-68, 2002 | 334 | 2002 |
| A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells G Mondanelli, R Bianchi, MT Pallotta, C Orabona, E Albini, A Iacono, ... Immunity 46 (2), 233-244, 2017 | 271 | 2017 |
| A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice U Grohmann, F Fallarino, R Bianchi, C Orabona, C Vacca, MC Fioretti, ... The Journal of experimental medicine 198 (1), 153-160, 2003 | 254 | 2003 |
| T cell apoptosis by kynurenines F Fallarino, U Grohmann, C Vacca, C Orabona, A Spreca, MC Fioretti, ... Developments in tryptophan and serotonin metabolism, 183-190, 2003 | 240 | 2003 |
| IL-6 inhibits the tolerogenic function of CD8α+ dendritic cells expressing indoleamine 2, 3-dioxygenase U Grohmann, F Fallarino, R Bianchi, ML Belladonna, C Vacca, C Orabona, ... The Journal of Immunology 167 (2), 708-714, 2001 | 232 | 2001 |
| SOCS3 drives proteasomal degradation of indoleamine 2, 3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis C Orabona, MT Pallotta, C Volpi, F Fallarino, C Vacca, R Bianchi, ... Proceedings of the National Academy of Sciences 105 (52), 20828-20833, 2008 | 230 | 2008 |
| Toward the identification of a tolerogenic signature in IDO-competent dendritic cells C Orabona, P Puccetti, C Vacca, S Bicciato, A Luchini, F Fallarino, ... Blood 107 (7), 2846-2854, 2006 | 229 | 2006 |
| Cutting edge: autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells ML Belladonna, C Volpi, R Bianchi, C Vacca, C Orabona, MT Pallotta, ... The Journal of Immunology 181 (8), 5194-5198, 2008 | 205 | 2008 |
| TGF-β and kynurenines as the key to infectious tolerance ML Belladonna, C Orabona, U Grohmann, P Puccetti Trends in molecular medicine 15 (2), 41-49, 2009 | 171 | 2009 |
| Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy A Holtzhausen, F Zhao, KS Evans, M Tsutsui, C Orabona, DS Tyler, ... Cancer immunology research 3 (9), 1082-1095, 2015 | 163 | 2015 |
